STOCK TITAN

Niagen Bioscience Stock Price, News & Analysis

NAGE NASDAQ

Company Description

Welcome to the overview page for Niagen Bioscience (NAGE), where you can find comprehensive stock information and company updates.

Explore the latest news on strategic partnerships, quarterly and annual financial results, and regulatory filings including SEC reports and insider transactions.

Visualize performance trends using the interactive price chart, and keep track of upcoming events such as earnings calls, dividend dates, and investor conferences.

Stock Performance

$6.49
-0.15%
0.01
Last updated: December 18, 2025 at 16:53
-18.73 %
Performance 1 year
$502.0M

Insider Radar

Net Buyers
90-Day Summary
6,685
Shares Bought
0
Shares Sold
2
Transactions
Most Recent Transaction
Pamir Ozan (Chief Financial Officer) bought 4,465 shares @ $6.81 on Nov 14, 2025
Based on SEC Form 4 filings over the last 90 days.

Financial Highlights

$31,117,000
Revenue (TTM)
$3,609,000
Net Income (TTM)
$1,250,000
Operating Cash Flow

Upcoming Events

FEB
02
February 2, 2026 Product

Healthcare channel launch

Available via healthcare practitioner channel

Short Interest History

Last 12 Months
Loading short interest data...

Days to Cover History

Last 12 Months
Loading days to cover data...

Frequently Asked Questions

What is the current stock price of Niagen Bioscience (NAGE)?

The current stock price of Niagen Bioscience (NAGE) is $6.5 as of December 18, 2025.

What is the market cap of Niagen Bioscience (NAGE)?

The market cap of Niagen Bioscience (NAGE) is approximately 502.0M. Learn more about what market capitalization means .

What is the revenue (TTM) of Niagen Bioscience (NAGE) stock?

The trailing twelve months (TTM) revenue of Niagen Bioscience (NAGE) is $31,117,000.

What is the net income of Niagen Bioscience (NAGE)?

The trailing twelve months (TTM) net income of Niagen Bioscience (NAGE) is $3,609,000.

What is the earnings per share (EPS) of Niagen Bioscience (NAGE)?

The diluted earnings per share (EPS) of Niagen Bioscience (NAGE) is $0.04 on a trailing twelve months (TTM) basis. Learn more about EPS .

What is the operating cash flow of Niagen Bioscience (NAGE)?

The operating cash flow of Niagen Bioscience (NAGE) is $1,250,000. Learn about cash flow.

What is the profit margin of Niagen Bioscience (NAGE)?

The net profit margin of Niagen Bioscience (NAGE) is 11.60%. Learn about profit margins.

What is the operating margin of Niagen Bioscience (NAGE)?

The operating profit margin of Niagen Bioscience (NAGE) is 10.24%. Learn about operating margins.

What is the gross margin of Niagen Bioscience (NAGE)?

The gross profit margin of Niagen Bioscience (NAGE) is 65.00%. Learn about gross margins.

What is the current ratio of Niagen Bioscience (NAGE)?

The current ratio of Niagen Bioscience (NAGE) is 3.88, indicating the company's ability to pay short-term obligations. Learn about liquidity ratios.

What is the gross profit of Niagen Bioscience (NAGE)?

The gross profit of Niagen Bioscience (NAGE) is $20,226,000 on a trailing twelve months (TTM) basis.

What is the operating income of Niagen Bioscience (NAGE)?

The operating income of Niagen Bioscience (NAGE) is $3,185,000. Learn about operating income.